# Allergy Relief

NDC: 63868-669
Generic name: loratadine
Labeler / Manufacturer: CHAIN DRUG MARKETING ASSOCIATION INC.
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20180901
Marketing ended: 20260731
FDA application: ANDA206214

## Active ingredients

- LORATADINE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63868-669"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63868-669
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=18eaaeb7-1408-4621-bf88-1dc5cb06a9b3